---
figid: PMC10538262__JCMM-27-2922-g001
pmcid: PMC10538262
image_filename: JCMM-27-2922-g001.jpg
figure_link: /pmc/articles/PMC10538262/figure/jcmm17863-fig-0007/
number: FIGURE 7
figure_title: ''
caption: 'MTHFD2 promoted the expression of PD‐L1 via the JAK/STAT signalling pathway
  (A) Cell viability CCK‐8 assay. (B) Representative images of wound healing assay.
  (C) Cell apoptosis was measured by flow cytometry. (D) PD‐L1 surface‐antigen detection
  using immunofluorescent staining. (Scale bar represents 20 μm) (E) WB analysis of
  PD‐L1, cyclin D1, Bcl‐2, Bax and JAK/STAT signalling pathway‐related proteins expression.
  (* vs. shNC p < 0.05; ** vs. shNC p < 0.01; # vs. shMTHFD2 p < 0.05; ## vs. shMTHFD2
  p < 0.01).'
article_title: MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling
  pathway in bladder cancer.
citation: Linzhi Li, et al. J Cell Mol Med. 2023 Oct;27(19):2922-2936.
year: '2023'

doi: 10.1111/jcmm.17863
journal_title: Journal of Cellular and Molecular Medicine
journal_nlm_ta: J Cell Mol Med
publisher_name: John Wiley and Sons Inc.

keywords:
- bladder cancer (BC)
- malignant phenotype
- MTHFD2
- PD‐L1
- poor prognosis

---
